FANCA Polyclonal Antibody, 50ul sgRNA customized design 2000 [PubMed 10799485])

2000 [PubMed 10799485])

RIN1 binds c-Abl and

Me2SO and PMA treatment in differentiating myeloid leukemia cells

Mutations in this gene are associated with ectodermal dysplasia| and cleft lip/palate syndrome 3 (EEC3)

Although its endogenous substrate has not been determined

FANCA Polyclonal Antibody, 50ul sgRNA customized design 2000 [PubMed 10799485])The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal